Insulet Shares Plunge After Q2 Beat, Company Narrows Revenue Growth Target
Insulet Corporation reported second-quarter 2026 results that beat estimates on both adjusted EPS and revenue, but the stock plunged in pre-market trading after management trimmed its full-year revenue growth forecast. While adjusted EPS and revenue exceeded expectations, the reduced revenue growth outlook, a recent analyst downgrade and an ongoing…